Assessing Extracellular Vesicle Turnover In Vivo Using Highly Sensitive Phosphatidylserine‐Binding Reagents
Advanced Science · 2025
DOI: 10.1002/advs.202507624 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Lavinia Flaskamp und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Immunology, Faculty of Medicine, BMC, LMU Munich, Großhaderner Strasse 9, 82152, Planegg, Germany. Hauptthemen laut MEDLINE: Extracellular Vesicles, Phosphatidylserines. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft (German Research Foundation), European Union, European Commission.
Abstract (Originalsprache)
Extracellular vesicles (EVs) are emerging as crucial players in cell communication and hold great promise as biomarkers and therapeutic tools. However, their diversity makes it challenging to detect, classify, and utilize them effectively, which limits their clinical applicability. A key challenge is the lack of reliable markers to identify EVs consistently. In this study, a novel high‐affinity phosphatidylserine (PS)‐binding reagent is introduced for EV analysis. PS is known as a marker of apoptotic cells and activated platelets, but its presence on EVs is debated due to variations in lipid composition. By comparing multiple PS‐binding reagents, including MFG‐E8 derivatives and Annexin V, it is demonstrated that ≈90% of EVs in human and mouse blood carry PS. Using the optimized reagent, the first in vivo insights into EV turnover are provided, showing that PS+ EVs in mouse blood are rapidly cleared (≈50% within 30 min) but persist on immune cells in the spleen. This discovery increases the potential of EVs as disease biomarkers and therapeutic targets by improving EV detection and isolation as well as opening the door for standardized quantification and diagnostic monitoring.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Immunology, Faculty of Medicine, BMC, LMU Munich, Großhaderner Strasse 9, 82152, Planegg, Germany.
- German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
ORCID-Profile: Thomas Brocker
Förderung
- Deutsche Forschungsgemeinschaft (German Research Foundation)
- European Union
- European Commission
Zitieren
APA
Flaskamp, L., Prechtl, M., Scheck, A., Hu, W., Ried, C., Kislinger, G., Simons, M., Krug, A. B., Kranich, J., & Brocker, T. (2025). Assessing Extracellular Vesicle Turnover In Vivo Using Highly Sensitive Phosphatidylserine‐Binding Reagents. Advanced Science. https://doi.org/10.1002/advs.202507624
Vancouver
Flaskamp L, Prechtl M, Scheck A, Hu W, Ried C, Kislinger G, et al. Assessing Extracellular Vesicle Turnover In Vivo Using Highly Sensitive Phosphatidylserine‐Binding Reagents. Advanced Science. 2025. doi:10.1002/advs.202507624
BibTeX
@article{Flaskamp2025,
author = {Flaskamp, Lavinia and Prechtl, Monica and Scheck, Annkathrin and Hu, Wenbo and Ried, Christine and Kislinger, Georg and Simons, Mikael and Krug, Anne B and Kranich, Jan and Brocker, Thomas},
title = {Assessing Extracellular Vesicle Turnover In Vivo Using Highly Sensitive Phosphatidylserine‐Binding Reagents},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202507624}
}
EUVIMED